Table 1.
Demographics and characteristics of the vaccinated cohorts
| CV-AZ | AZ-CV | CV-CV | AZ-AZ | |
|---|---|---|---|---|
| n | 46 | 48 | 90 | 90 |
| Mean (range) age, years | 41.1 (18.0–64.0) | 43.1 (23.0–59.0) | 42.6 (24.0–59.0) | 47.6 (19.0–85.0) |
| Sex | ||||
| Male (%) | 26 (56.5) | 21 (43.8) | 49 (54.4) | 40 (44.4) |
| Female (%) | 20 (43.5) | 27 (56.2) | 41 (45.6) | 50 (55.6) |
| Time interval between first and second doses | ||||
| Median (range), days | 27.0 (27.0–28.0) | 70.0 (70.0–71.0) | 26.0 (21.0–28.0) | 70.0 (70.0–73.0) |
| Time interval between the second dose and blood sampling | ||||
| Median (range), days | 31.0 (30.0–35.0) | 32.0 (30.0–35.0) | 31.0 (28.0–49.0) | 30.0 (22.0–41.0) |
| Preexisting co-morbidities, n (%) | ||||
| Allergic diseases (allergic rhinitis, asthma, other allergies) | 1 (3%) | 2 (5%) | 8 (9%) | 9 (10%) |
| Cardiovascular diseases (Diabetes mellitus, hypertension, dyslipidemia, heart diseases) | 7 (16%) | 5 (11%) | 13 (15%) | 21 (24%) |
| Others (Migraine, thyroid disease, etc.) | 3 (7%) | 2 (5%) | 3 (4%) | 7 (8%) |